Foskett, A. M., Bazhanov, N., Ti, X., Tiblow, A., Bartosh, T. J., & Prockop, D. J. (2013). Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs. American Physiological Society.
Chicago-tyylinen lähdeviittausFoskett, Andrea M., Nikolay Bazhanov, XinYu Ti, April Tiblow, Thomas J. Bartosh, ja Darwin J. Prockop. Phase-directed Therapy: TSG-6 Targeted to Early Inflammation Improves Bleomycin-injured Lungs. American Physiological Society, 2013.
MLA-viiteFoskett, Andrea M., et al. Phase-directed Therapy: TSG-6 Targeted to Early Inflammation Improves Bleomycin-injured Lungs. American Physiological Society, 2013.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.